Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3

Past studies have shown that histone deacetylase (HDAC) and mutant BRAF (v-Raf murine sarcoma viral oncogene homolog B1) inhibitors synergistically kill melanoma cells with activating mutations in BRAF. However, the mechanism(s) involved remains less understood. Here, we report that combinations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, F, Guo, S T, Jin, L, Jiang, C C, Wang, C Y, Croft, A, Chi, M N, Tseng, H-Y, Farrelly, M, Atmadibrata, B, Norman, J, Liu, T, Hersey, P, Zhang, X D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702278/
https://www.ncbi.nlm.nih.gov/pubmed/23744355
http://dx.doi.org/10.1038/cddis.2013.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702278/
https://www.ncbi.nlm.nih.gov/pubmed/23744355
http://dx.doi.org/10.1038/cddis.2013.192

Ejemplares similares